2016
DOI: 10.4103/0255-0857.174100
|View full text |Cite
|
Sign up to set email alerts
|

Current trend of antibiotic sensitivity of Salmonella typhi and other Salmonellae in Mumbai: A 5 years study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
2
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 3 publications
1
2
0
Order By: Relevance
“…Given that fluoroquinolones remain an important therapeutic option for typhoid fever, it was worrisome to note that 45 per cent of the isolates were resistant to ciprofloxacin. Our results were in concordance with an earlier report on an increase in quinolone resistance amongst strains in India 27 . The emergence of drug-resistant S .…”
Section: Discussionsupporting
confidence: 94%
“…Given that fluoroquinolones remain an important therapeutic option for typhoid fever, it was worrisome to note that 45 per cent of the isolates were resistant to ciprofloxacin. Our results were in concordance with an earlier report on an increase in quinolone resistance amongst strains in India 27 . The emergence of drug-resistant S .…”
Section: Discussionsupporting
confidence: 94%
“…In the present study, 17.9% of isolates showed resistance to AZM (Table 3), a macrolide antimicrobial used for the limited treatment of MDR Salmonella infections [8, 46]. In recent years, AZM has been used for typhoid treatment due to the increased prevalence of MDR Salmonella isolates, which has caused serious problems in antimicrobial selection.…”
Section: Discussionmentioning
confidence: 71%
“…24 A recent study from Mumbai found all isolates of Salmonella Typhi and Salmonella Paratyphi A to be susceptible to azithromycin. 25 While comparing the 2012 CLSI guidelines with the previous 2011 guidelines, it was found that as per the 2012 CLSI guidelines for ciprofloxacin susceptibility, only 3% of their strains were susceptible, and 88% were moderately susceptible, as compared with the 2011 CLSI breakpoints in which 95% were susceptible. Thus, reinterpreting MIC results with 2012 guidelines indicates the end of the road for ciprofloxacin as the drug of choice for Salmonella Typhi.…”
Section: Discussionmentioning
confidence: 99%